Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
Condition:   Herpes Genitalis Interventions:   Biological: HDIT101;   Drug: Valaciclovir;   Biological: HDIT101 placebo;   Drug: Valaciclovir placebo Sponsor:   Heidelberg ImmunoTherapeutics GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
Condition:   Herpes Genitalis Interventions:   Biological: HDIT101;   Drug: Valaciclovir;   Biological: HDIT101 placebo;   Drug: Valaciclovir placebo Sponsor:   Heidelberg ImmunoTherapeutics GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials

Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum
Conditions:   Atopic Dermatitis With a History of Eczema Herpeticum;   Atopic Dermatitis Without a History of Eczema Herpeticum;   Health Controls Without Atopy Intervention:   Biological: Xolair Sponsors:   National Jewish Health;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2019 Category: Research Source Type: clinical trials